SITE
SITE
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$1.00M
Insider Sales
0
$0
Total Volume
$1.00M
1 transactions
Net Activity
+$1.00M
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
- •High accumulation: total purchase value exceeds $1M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Black Doug
CEO
$1.00M total
Quick Actions
SITE has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. SITE ranks #353 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at SITE (SITE) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $1.00M.
The net insider activity for SITE shows a net buying bias of $1.00M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Black Doug (CEO), who traded 9.1K shares valued at $1.00M on Oct 30, 2026.
3 Reasons SITE is Risky and 1 Stock to Buy Instead
Army Prepositioned Stock-2 Eygelshoven Interim Site Manager (the Netherlands)
Discover and perfect great content with Adobe Stock’s new site
3 Reasons to Avoid SITE and 1 Stock to Buy Instead
Johnson & Johnson's surgical robot has FDA authorization for 10 procedures. A Houston hospital will install it first.
Army Prepositioned Stock-2 Dülmen Site Manager (Germany)
FAQs About SITE Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for SITE.